PANENI, Maria Silvia
 Distribuzione geografica
Continente #
NA - Nord America 2.871
EU - Europa 1.213
AS - Asia 1.150
SA - Sud America 167
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.439
Nazione #
US - Stati Uniti d'America 2.848
SG - Singapore 478
CN - Cina 320
SE - Svezia 301
UA - Ucraina 258
BR - Brasile 129
DE - Germania 125
FI - Finlandia 119
HK - Hong Kong 116
IT - Italia 95
VN - Vietnam 51
PL - Polonia 50
TR - Turchia 48
RU - Federazione Russa 47
KR - Corea 45
FR - Francia 42
GB - Regno Unito 40
BG - Bulgaria 38
IE - Irlanda 37
MY - Malesia 23
AR - Argentina 21
BE - Belgio 16
BD - Bangladesh 13
CA - Canada 13
CZ - Repubblica Ceca 11
IN - India 11
JP - Giappone 10
MA - Marocco 8
ZA - Sudafrica 7
CH - Svizzera 6
EC - Ecuador 6
KE - Kenya 6
MX - Messico 6
NL - Olanda 6
IQ - Iraq 5
AT - Austria 4
CO - Colombia 4
LT - Lituania 4
SN - Senegal 4
VE - Venezuela 4
DZ - Algeria 3
ET - Etiopia 3
ID - Indonesia 3
KZ - Kazakistan 3
PK - Pakistan 3
AL - Albania 2
ES - Italia 2
EU - Europa 2
HN - Honduras 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
CL - Cile 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
LB - Libano 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 5.439
Città #
Ann Arbor 534
Woodbridge 363
Houston 262
Singapore 260
Jacksonville 222
Ashburn 221
Chandler 218
Fairfield 131
Hong Kong 116
Wilmington 101
Hefei 87
Beijing 79
Princeton 74
Seattle 62
Boardman 59
Cambridge 47
Seoul 45
Columbus 43
Los Angeles 40
Sofia 38
Dublin 37
Zgierz 35
Helsinki 34
Düsseldorf 32
Munich 29
Kocaeli 26
Moscow 22
Bremen 21
Dearborn 21
São Paulo 20
Izmir 19
Trieste 18
Buffalo 17
Falkenstein 17
Brussels 16
Ho Chi Minh City 16
New York 14
Chicago 13
Dallas 13
Frankfurt am Main 13
Hanoi 12
San Diego 12
Santa Clara 11
Turku 11
Warsaw 11
Brno 10
Falls Church 10
Redwood City 9
San Jose 9
Tokyo 9
Poplar 8
Shanghai 8
Verona 8
Casablanca 7
Des Moines 7
Guangzhou 7
Milan 6
Montreal 6
Nanjing 6
Orem 6
Phoenix 6
The Dalles 6
Brasília 5
Chennai 5
Grafing 5
London 5
Nairobi 5
Quito 5
Redondo Beach 5
Bern 4
Bismarck 4
Brooklyn 4
Dakar 4
Denver 4
Rome 4
Wroclaw 4
Almaty 3
Amsterdam 3
Ankara 3
Augusta 3
Jinan 3
Lauterbourg 3
Mexico City 3
Nanchang 3
Norwalk 3
Pordenone 3
Porto Alegre 3
Roubaix 3
San Juan 3
Toronto 3
Trescore Balneario 3
Addis Ababa 2
Algiers 2
Atlanta 2
Belo Horizonte 2
Birmingham 2
Bishkek 2
Buenos Aires 2
Cape Town 2
Charlotte 2
Totale 3.746
Nome #
3-Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: A novel class of potent tubulin inhibitors 234
Analogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach 232
Antiviral and cytotoxic activities of aminoarylazo compoundsand aryltriazene derivatives 193
Antimicrobial and cytotoxic arylazoenamines. Part III: Antiviral activity of selected classes of arylazoenamines 190
T670X kit mutations in gastrointestinal stromal tumors: making sense of missense 189
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma1 receptor ligand based on a series of benzo[d]oxazol-2(3H)-one derivatives 188
"Fatty" nucleoside analogs as HCV NS5b inhibitors 187
Many-Scale Simulation of ABS/PC Blends for the Automotive Industry 187
Functional analysis and molecular modelling show a preserved wild type activity of p53 C238Y 182
A simple but effective three-dimensional chemical feature-based pharmacophore model for diketo acid derivatives as hepatitis C virus RNA-dependent RNA-polymerase inhibitors 178
A new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: A coupled experimental and modeling investigation 177
Can computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm 166
Upgrading polymeric materials from post industrial rejects: a multiscale simulation approach 155
Integrated process of design, synthesis and physicochemical characterization of nanovectors for active drug delivery: the cyclodextrin-folate-bioconjugate example 154
Pharmacophore modeling, resistant mutant isolation, docking, and MM-PBSA analysis: Combined experimental/computer-assisted approaches to identify new inhibitors of the bovine viral diarrhea virus (BVDV) 153
Fighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm 150
Design, synthesis and activity of hindered nucleoside analogs with anti-Flaviviridae activity, and their interaction with RdRp 148
Diblock copolymers for the automotive industry: the mesoscopic approach 148
A talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding 147
Computer simulation of polymer-organoclay nanocomposites for packaging applications: From binding energy to interlayer spacing predictions 146
Angels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer. 140
Delivered to Perfection at Nanoscale. A Coupled Multiscale Simulation/Experimental Investigation of Protein Release from Nanochannel Delivery Systems 138
Design, synthesis and characterization of folate-cyclodextrin bioconjugate for active drug delivery: results from combined computational and experimental efforts 138
Genotype-phenotype correlations of myosin mutations: a molecular simulation study 136
Release of Proteins from Nanochannel Delivery Systems: a Coupled Many-Scale Simulation - Experimental Investigation 132
Prediction fo HIV-1 resistance to NNRITs: a computer-aided molecular-based rationale 131
Changes and challenges: GIST, mutated C-KIT and imatinib resistance 129
Of life and Death: Chronic Myeloid Leukemia and the Bcr-Abl/Imatinib Paradigm 119
Take a walk on the nano side: structural and energetical analysis of ATP-binding pocket mutations of the cardiac beta-myosin heavy chain implicated in familial hypertrophic cardiomyopathy 114
Where are we in HIV research? A novel, computer-based strategy predicting resistance to HIV-1 NNRTIs 113
PVC/LDPE incompatible blends for industrial applications: A computational multiscale approach 113
Molecular modeling of hydrogen storage in carbon nanotubes: A combined molecular dynamics/ab initio orbital study 109
P53 mutations in sporadic and NF1 related malignant peripheral nerve sheath tumors (MPNST): from clinical evidences to a molecular rationale 108
Upgrading block co-polymers from post industrial rejects: a multiscale simulation approach 102
Three-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase 97
Is tailor-fitting always the best choice? The case of mutations in GISTs and Imatinib 86
Novel Aryl Diketo Acids (ADKs) as Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA-Polymerase: Better Understanding Through Molecular Modeling 86
Totale 5.495
Categoria #
all - tutte 16.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021227 0 0 0 0 0 0 7 44 25 71 21 59
2021/2022420 15 36 36 40 2 32 25 12 68 38 18 98
2022/2023621 52 85 52 95 86 102 4 41 73 2 21 8
2023/2024286 23 20 18 24 34 29 21 65 1 4 17 30
2024/2025785 22 17 32 87 87 75 76 20 113 82 71 103
2025/20261.051 208 107 122 219 189 196 10 0 0 0 0 0
Totale 5.495